![Simon John Peat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Simon John Peat
Fundador en Project Better Energy Ltd. .
Origen de la red de primer grado Simon John Peat.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Se Group Ltd.
![]() Se Group Ltd. Miscellaneous Commercial ServicesCommercial Services SE Group Ltd. is a British company that provides professional, scientific, and technical services. The private company was founded in 2013 and is based in Brighouse, UK.
7
| Private Company | Miscellaneous Commercial Services | 7 |
Project Better Energy Ltd.
![]() Project Better Energy Ltd. Electric UtilitiesUtilities Project Better Energy Ltd. is a British company that generates electric power. The private company is based in Burton-on-Trent, UK. and has subsidiaries in United Kingdom. Project Better Energy was founded in 2012.
2
| Holding Company | Electric Utilities | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Simon John Peat a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
GRESHAM TECHNOLOGIES PLC | Packaged Software | President | |
Biosceptre (Aust) Pty Ltd.
![]() Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Pharmaceuticals: Major | Chairman | |
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Biotechnology | Chairman |
Estadísticas
Internacional
Reino Unido | 3 |
Australia | 2 |
Sectorial
Health Technology | 3 |
Technology Services | 2 |
Operativa
Director/Board Member | 10 |
Chairman | 2 |
President | 1 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Simon John Peat
- Conexiones Empresas